Cargando…

Validation of Persian Individualized Neuromuscular Quality of Life in patients with muscular dystrophies

Background: Neuromuscular disorders affect physical and mental aspects of a patient and in other words alter the patients’ quality of life (QOL). In the present study, we investigated the validity and reliability of the Persian version of Individualized Neuromuscular QOL (INQOL) to provide a better...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moradi, Kamyar, Jamal-Omidi, Shirin, Masoudi, Maryam, Bagheri, Sayna, Nafissi, Shahriar, Fatehi, Farzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482662/

Ejemplares similares

Validation of myasthenia gravis activity of daily living questionnaire: Persian version
por: Faghani, Shahriar, et al.
Publicado: (2022)

Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)

Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire
por: Shamshiri, Hosein, et al.
Publicado: (2013)

Ullrich Congenital Muscular Dystrophy (UCMD): Clinical and Genetic Correlations
por: BOZORGMEHR, Bita, et al.
Publicado: (2013)

Validation of the Persian version of the dysphagia handicap index in patients with neurological disorders
por: Barzegar-Bafrooei, Ebrahim, et al.
Publicado: (2016)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
por: Fatehi, Farzad, et al.
Publicado: (2013)

An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis
por: Fathi, Davood, et al.
Publicado: (2019)

Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar
por: Fatehi, Farzad, et al.
Publicado: (2021)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience
por: Ziaadini, Bentolhoda, et al.
Publicado: (2022)

Olfactory dysfunction in persian patients suffering from parkinson's disease
por: Soltanzadeh, Akbar, et al.
Publicado: (2011)

The third Iranian and the second joint French-Iranian neuromuscular meeting
por: Sinaei, Farnaz, et al.
Publicado: (2017)

Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases
por: Karimi, Narges, et al.
Publicado: (2021)

Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis
por: Vahabi, Zahra, et al.
Publicado: (2021)

Lamin A/C–mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy
por: Méjat, Alexandre, et al.
Publicado: (2009)

I-19 Neuromuscular electrical stimulation training in facio-scapulo-humeral muscular dystrophy
por: Sacconi, S.
Publicado: (2011)

Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the Neuromuscular Centre Ulm
por: WOLLINSKY, KURT H., et al.
Publicado: (2012)

Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: Impacts, challenges, and opportunities
por: Ng, Sean Y, et al.
Publicado: (2020)

Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections
por: Paredes-Redondo, Amaia, et al.
Publicado: (2021)

Validation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients
por: Maleki, Iradj, et al.
Publicado: (2015)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
por: Ogundele, Michael, et al.
Publicado: (2021)

The Muscular Dystrophy Association’s neuroMuscular ObserVational Research Data Hub (MOVR): Design, Methods, and Initial Observations
por: Kilroy, Elisabeth A, et al.
Publicado: (2023)

Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
por: Tsoumpra, Maria K., et al.
Publicado: (2019)

Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy
por: Hui, Tiankun, et al.
Publicado: (2021)

T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis
por: Lemos, Julia Pereira, et al.
Publicado: (2023)

Psychometric properties of Persian version of the multifactor leadership questionnaire (MLQ)
por: Bagheri, Rezaali, et al.
Publicado: (2015)

Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)

Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report
por: Kim, Ji Eun, et al.
Publicado: (2017)

Genotype–Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry
por: Lim, Kenji Rowel Q., et al.
Publicado: (2020)

Metformin Increases Sarcolemma Integrity and Ameliorates Neuromuscular Deficits in a Murine Model of Duchenne Muscular Dystrophy
por: Dong, Xia, et al.
Publicado: (2021)

Beneficial impacts of neuromuscular electrical stimulation on muscle structure and function in the zebrafish model of Duchenne muscular dystrophy
por: Kilroy, Elisabeth A, et al.
Publicado: (2022)

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Validity and reliability of Persian version of Listening Styles Profile-Revised (LSP- R) in Iranian students
por: Fatehi, Zahra, et al.
Publicado: (2017)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy
por: Haddix, Seth G., et al.
Publicado: (2018)

Validation of Persian Version of Patient-Rated Wrist and Hand Evaluation: Confirmatory Factor Analysis and Rasch Analysis
por: Farzad, Maryam, et al.
Publicado: (2020)

Evaluation of the Reliability and Validity of the Persian Version of the Fatigue Assessment Scale in Iranian Sarcoidosis Patients
por: Lookzadeh, Somayeh, et al.
Publicado: (2018)

Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy
por: Alonso-Pérez, Jorge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_id41p5kreuv0vadpsk99h2cjs2